| Financial Year |
March 31 2023 |
| Monetary Funds |
1,174,335,128.70 |
| Held-for-trading Financial Assets |
181,279,877.03 |
| Notes Receivable |
7,907,807.92 |
| Accounts Receivable |
452,776,387.76 |
| Advances to Suppliers |
21,838,139.96 |
| Other Receivables |
11,056,579.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
272,832,829.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
109,159,884.88 |
| Total Current Assets |
2,656,265,873.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,536,519,216.83 |
| Under-construction Projects |
49,355,355.76 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
414,072,769.08 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
26,433,331.71 |
| Deferred Income Tax Assets |
18,046,146.59 |
| Other Non-Current Assets |
3,385,365.10 |
| Sub-Total of Non-Current Assets |
3,050,001,406.32 |
| Total Assets |
5,706,267,280.08 |
| Short-Term Loans |
134,098,150.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
120,420,298.89 |
| Accounts Payable |
278,160,109.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,314,877.02 |
| Taxes Payable |
18,046,103.61 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
50,227,279.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,259,467.65 |
| Other Current Liabilities |
5,962,649.61 |
| Sub-Total of Current Liabilities |
664,981,319.42 |
| Long-term Loans |
160,000,000.00 |
| Bonds Payable |
489,598,340.66 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
21,760,440.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
714,579,673.79 |
| Total Liabilities |
1,379,560,993.21 |
| Paid-In Capital(Or Share Stock) |
408,716,044.00 |
| Capital Surplus |
805,873,809.25 |
| Surplus Reserve |
272,011,440.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,745,542,871.61 |
| Minority Stockholder's Interest |
-4,837,791.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,331,544,078.67 |
| Owner's Equity（Stockholder's Equity） |
4,326,706,286.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,706,267,280.08 |
